273 related articles for article (PubMed ID: 19861346)
1. The role of the central renin-angiotensin system in Parkinson's disease.
Mertens B; Vanderheyden P; Michotte Y; Sarre S
J Renin Angiotensin Aldosterone Syst; 2010 Mar; 11(1):49-56. PubMed ID: 19861346
[TBL] [Abstract][Full Text] [Related]
2. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
3. Prevention of remodeling in congestive heart failure due to myocardial infarction by blockade of the renin-angiotensin system.
Guo X; Saini HK; Wang J; Gupta SK; Goyal RK; Dhalla NS
Expert Rev Cardiovasc Ther; 2005 Jul; 3(4):717-32. PubMed ID: 16076281
[TBL] [Abstract][Full Text] [Related]
4. Progression of cardiovascular damage: the role of renin-angiotensin system blockade.
Probstfield JL; O'Brien KD
Am J Cardiol; 2010 Jan; 105(1 Suppl):10A-20A. PubMed ID: 20102969
[TBL] [Abstract][Full Text] [Related]
5. The renin-angiotensin system and diabetic nephropathy.
Gurley SB; Coffman TM
Semin Nephrol; 2007 Mar; 27(2):144-52. PubMed ID: 17418683
[TBL] [Abstract][Full Text] [Related]
6. Role of angiotensin receptor blockers in the prevention and treatment of arrhythmias.
Garg S; Narula J; Marelli C; Cesario D
Am J Cardiol; 2006 Mar; 97(6):921-5. PubMed ID: 16516603
[TBL] [Abstract][Full Text] [Related]
7. Critical role for p47phox in renin-angiotensin system activation and blood pressure regulation.
Grote K; Ortmann M; Salguero G; Doerries C; Landmesser U; Luchtefeld M; Brandes RP; Gwinner W; Tschernig T; Brabant EG; Klos A; Schaefer A; Drexler H; Schieffer B
Cardiovasc Res; 2006 Aug; 71(3):596-605. PubMed ID: 16843452
[TBL] [Abstract][Full Text] [Related]
8. Recent changes in the landscape of combination RAS blockade.
Epstein BJ; Smith SM; Choksi R
Expert Rev Cardiovasc Ther; 2009 Nov; 7(11):1373-84. PubMed ID: 19900020
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of protective effects induced by blockade of the renin-angiotensin system: novel role of the pancreatic islet angiotensin-generating system in Type 2 diabetes.
Leung PS
Diabet Med; 2007 Feb; 24(2):110-6. PubMed ID: 17257271
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin II type 1 receptor blockade: high hopes sent back to reality?
Grothusen A; Divchev D; Luchtefeld M; Schieffer B
Minerva Cardioangiol; 2009 Dec; 57(6):773-85. PubMed ID: 19942847
[TBL] [Abstract][Full Text] [Related]
11. Renin-angiotensin inhibition reverses advanced cardiac remodeling in aging spontaneously hypertensive rats.
Ito N; Ohishi M; Yamamoto K; Tatara Y; Shiota A; Hayashi N; Komai N; Yanagitani Y; Rakugi H; Ogihara T
Am J Hypertens; 2007 Jul; 20(7):792-9. PubMed ID: 17586415
[TBL] [Abstract][Full Text] [Related]
12. Renin angiotensin system blockade and cardiovascular outcomes in patients with chronic kidney disease and proteinuria: a meta-analysis.
Balamuthusamy S; Srinivasan L; Verma M; Adigopula S; Jalandhara N; Hathiwala S; Smith E
Am Heart J; 2008 May; 155(5):791-805. PubMed ID: 18440325
[TBL] [Abstract][Full Text] [Related]
13. Renin-angiotensin-aldosterone system blockade and renal protection: angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers?
Ruilope LM
Acta Diabetol; 2005 Apr; 42 Suppl 1():S33-41. PubMed ID: 15868118
[TBL] [Abstract][Full Text] [Related]
14. Dual blockade of the renin-angiotensin system in the progression of renal disease: the need for more clinical trials.
Fernandez-Juárez G; Barrio V; de Vinuesa SG; Goicoechea M; Praga M; Luño J
J Am Soc Nephrol; 2006 Dec; 17(12 Suppl 3):S250-4. PubMed ID: 17130270
[TBL] [Abstract][Full Text] [Related]
15. [Renin-angiotensin system in atherosclerosis].
Fukuda D; Sata M
Nihon Rinsho; 2006 Apr; 64(4):805-9. PubMed ID: 16613201
[TBL] [Abstract][Full Text] [Related]
16. Inhibiting the renin-angiotensin system: why and in which patients.
Berra K; Miller NH
J Am Acad Nurse Pract; 2009 Jan; 21(1):66-75. PubMed ID: 19125897
[TBL] [Abstract][Full Text] [Related]
17. From mitochondria to disease: role of the renin-angiotensin system.
de Cavanagh EM; Inserra F; Ferder M; Ferder L
Am J Nephrol; 2007; 27(6):545-53. PubMed ID: 17785964
[TBL] [Abstract][Full Text] [Related]
18. Dual renin-angiotensin system blockade and kidney disease.
Parving HH; Brenner BM; McMurray JJ; de Zeeuw D; Haffner SM; Solomon SD; Chaturvedi N; Pfeffer MA
J Am Coll Cardiol; 2009 Jul; 54(3):278-9; author reply 279-80. PubMed ID: 19589445
[No Abstract] [Full Text] [Related]
19. Renin-angiotensin system and atherothrombotic disease: from genes to treatment.
Jacoby DS; Rader DJ
Arch Intern Med; 2003 May; 163(10):1155-64. PubMed ID: 12767951
[TBL] [Abstract][Full Text] [Related]
20. Brain angiotensin enhances dopaminergic cell death via microglial activation and NADPH-derived ROS.
Rodriguez-Pallares J; Rey P; Parga JA; Muñoz A; Guerra MJ; Labandeira-Garcia JL
Neurobiol Dis; 2008 Jul; 31(1):58-73. PubMed ID: 18499466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
